Skip to main content

Hoge Stephen's Form 4 filing

Moderna, Inc. (MRNA) · filed Nov 26, 2021

Accession no.
0000899243-21-046142
Filed
Nov 26, 2021
Trade date
Jan 24-Nov 24, 2021
Filing delay
306 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 13 non-derivative transactions and 3 derivative transactions. Open-market sales total $5.50M. It was filed 306 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoge StephenCIK 0001760669Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 23, 2021Common StockMOption exerciseAcquired+5,000$10.90+$54,5001,614,597Direct
Nov 23, 2021Common StockMOption exerciseAcquired+10,000$0.99+$9,9001,624,597Direct
Nov 23, 2021Common StockSSaleDisposed−196$270.19F2−$52,957.241,624,401Direct
Nov 23, 2021Common StockSSaleDisposed−1,600$271.84F3−$434,9441,622,801Direct
Nov 23, 2021Common StockSSaleDisposed−1,368$273.10F4−$373,600.81,621,433Direct
Nov 23, 2021Common StockSSaleDisposed−1,863$274.19F5−$510,815.971,619,570Direct
Nov 23, 2021Common StockSSaleDisposed−1,977$275.22F6−$544,109.941,617,593Direct
Nov 23, 2021Common StockSSaleDisposed−2,096$276.32F7−$579,166.721,615,497Direct
Nov 23, 2021Common StockSSaleDisposed−5,300$277.25F8−$1,469,4251,610,197Direct
Nov 23, 2021Common StockSSaleDisposed−200$278.48F9−$55,6961,609,997Direct
Nov 23, 2021Common StockSSaleDisposed−400$280.14F10−$112,0561,609,597Direct
Jan 24, 2021Common StockMOption exerciseAcquired+5,000$10.90+$54,5001,614,597Direct
Jan 24, 2021Common StockSSaleDisposed−5,000$273.01−$1,365,0501,609,597Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 23, 2021Common StockMOption exerciseDisposed−5,000$0.00$0191,972Direct
Nov 23, 2021Common StockMOption exerciseDisposed−10,000$0.00$0237,431Direct
Nov 24, 2021Common StockMOption exerciseDisposed−5,000$0.00$0186,972Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $269.86 to $270.50. Full information regarding the number of shares sold at each separate ice can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $271.52 to $272.50. Full information regarding the number of shares sold at each separate ice can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $272.62 to $273.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $273.72 to $274.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $274.80 to $275.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $275.85 to $276.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $277.08 to $277.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $278.15 to $278.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $279.80 to $280.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)